Blood pressure and lipid targets for the GEMINI and CAPABLE trials, based on JNC VI blood pressure and NCEP ATP lipid recommendations

<p><b>Copyright information:</b></p><p>Taken from "Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? The single pill of amlodipine/atorvastatin"</p><p></p><p> 2007;3(5):711-719.</p><p>Published online Jan 2007</p><p>PMCID:PMC2291315.</p><p>